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New drugs from natural sources have been targets of the drug discovery program and 
some bioactive compounds from macroalgae such as sulfated polysaccharides, steroids and 
diterpens have found their applications in the pharmaceutical industry.
[1,2]
 Consequently, 
we have investigated the chemical composition and the in vitro antitumor potential of the 
metabolites isolated from the macroalga Ulva rigida, collected from the Azorean coast, an 
environmentally healthy habitat with a high level of biodiversity. We hereby describe 
isolation of isofucosterol (1) and 7(E)-3-hidroxy-5, 6-epoxymegastigmane (2) from the 
methanol extract of Ulva rigida, collected in May of 2011 in the Sea of St Miguel Island - 
Azores archipelago. The process of isolation of these metabolites involved chlorophylls 
elimination by the method previously described
[3]
 and fractionation by column 
chromatography. The structures of 1 and 2 were established by 1D and 2D NMR spectral 
analysis and specific rotation as well as comparison of their spectral data with those 
described in the literature.
[4,5]
 Compounds 1 and 2 were evaluated for their capacity to 
inhibit the in vitro growth of three human cancer cell lines: MCF-7 (breast 
adenocarcinoma), NCI-H460 (non-small cell lung cancer) and A375-C5 (human skin cell 
line), using the protein binding dye SRB method. The results showed that compound 1 
exhibited only a weak activity against MCF-7 (GI50 = 122.2 ± 17.9 µM), NCI-H460 (GI50 = 
128.4 ± 32.4 µM), A375-C5 (GI50 = 119.2 ± 28.9 µM), while compound 2 was inactive 
against all the three cell lines (GI50 >200 µM). 
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